Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 28, 2015; 21(44): 12513-12518
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12513
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12513
Ref. | Incrusion criteria | Duration | Regression | Accuracy |
Suzuki et al[31], 2015 | Vienna C3 and C4 | NA | 26.0% | 0.0% |
Yamada et al[32], 2004 | Vienna C3 | 4.7Y | 0.0% | 2.7% |
Vienna C4 | 4.7Y | 0.0% | 10.0% | |
Saito et al[33], 2000 | Adenoma | 2Y | NA | 6.3% |
Kokkola et al[34], 1996 | Mild dysplasia | NA | NA | 0.0% |
(4% to moderate) | ||||
Bearzi et al[35], 1994 | LGD | NA | 49.4% | 32.1% |
Fertitta et al[36], 1993 | Moderate and severe dysplasia | 13M | NA | 33.0% |
Di Gregorio et al[37], 1993 | Mild dysplasia | NA | 74.0% | 7.0% |
Saraga et al[38], 1987 | Mild and moderate dysplasia | 42M | NA | 1.6% |
Severe dysplasia | 42M | NA | 86.0% |
- Citation: Kato M. Diagnosis and therapies for gastric non-invasive neoplasia. World J Gastroenterol 2015; 21(44): 12513-12518
- URL: https://www.wjgnet.com/1007-9327/full/v21/i44/12513.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i44.12513